TUMORMARKERSTHYROIDFERTILITYENDOCRINOLOGYDIABETESANEMIAPHOSPHOCALCIC AXISCARDIAC MARKERSHEPATITISOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONT.

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE

COM
MENTS

HBsAg

SURDINE 125 B
(100)

B-TUBE

74

 

2

A type

200 µl

30min/RT + 2.5h / 40±1°C

6 ~7 weeks

 

B type

30min/RT + 20+4h/RT

C type

15min/RT + 1h / 40±1°C

Anti-HBs

ANTISURDINE 125 B
(100)

B-TUBE

33.3

 

2

A type

100 µl

30min/RT + 20±4h/RT

6 ~7 weeks

 

B type

30min/RT + 4h/RT

Anti-HBc

ANTISURDINE 125 B
(100)

B-TUBE

18.5

 

2

A type

100 µl

20±4h/RT

6 ~7 weeks

 

B type

3h/40±1°C

Anti-HBc IgM

ANTISURDINE 125 MB
(100)

B-TUBE

37

 

2

 

5 µl

1h/40°C+20±4h/RT

6 ~7 weeks

 

HBeAg
HBeAb

EIDINE 125 BN
(100)

B-TUBE

18.5

 

3

 

200 µl

20±4h/RT+2h/40±1°C

6 ~7 weeks

 

100 µl

20±4h/RT+2h/40±1°C

Anti-HAV

HEPAVIDINE 125 A
(100)

B-TUBE

11.1

 

2

A type

10 µl

20±4h/RT

6 ~7 weeks

 

B type

 4h/40±1°C

Anti-HAV lgM

HEPAVIDINE 125 MA
(100)

B-TUBE

29.6

 

2

10 µl

 1h/40±1°C+4h/40±1°C

6 ~7 weeks

 

Anti-HCV

NANBDINE 125 C
(250)

B-TUBE

51.8

 

2

10 µl

30min/40°C + 2h / 40°C

6 ~7 weeks